Results 201 to 210 of about 1,588,155 (297)

Multidisciplinary Strategies to Manage Treatment-Related Dermatologic Toxicity and Improve Quality of Life in Cancer Patients: A Narrative Review. [PDF]

open access: yesHealthcare (Basel)
Monteiro JF   +6 more
europepmc   +1 more source

Dietary Patterns in Patients With Hidradenitis Suppurativa

open access: yesJEADV Clinical Practice, EarlyView.
Among 131 patients, 99 had mild‐to‐moderate hidradenitis suppurativa and 25 severe HS. The most reported diets were “healthy and varied” or “no specific diet”, and 11% practiced intermittent fasting. Patients with mild‐to‐moderate HS reported similar frequency of intake of cake/biscuits/sweets, fast food, fish, vegetables and wholegrain as patients ...
Maria Victoria Gerdes‐Miranda   +4 more
wiley   +1 more source

Toxicities of Fruquintinib in Gastrointestinal Malignancies: A Systematic Review and Meta-Analysis. [PDF]

open access: yesOncol Res
Jones DT   +15 more
europepmc   +1 more source

Individual and Societal Economic Burden of Atopic Dermatitis: A Nationwide Cohort Study

open access: yesJEADV Clinical Practice, EarlyView.
Using nationwide registry‐based data, this study estimates the economic burden of atopic dermatitis. Each individual with atopic dermatitis incurs an annual excess cost of €2172, driven mainly by foregone income rather than direct healthcare expenditure. ABSTRACT Background Atopic dermatitis (AD) imposes a significant economic burden for individuals as
Martino Renzi‐Lomholt   +7 more
wiley   +1 more source

Pietro Verri: The History of Smallpox Vaccination Through His Pencil

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT The last case of natural smallpox infection occurred in 1977, and the disease is considered eradicated since 1980. Throughout the history of medicine, early attempts to combat smallpox involved inoculation, a practice based on the observation that those who recovered from the disease became immune.
Omar Simonetti   +5 more
wiley   +1 more source

Cutaneous Eruptions Associated With Tumour Infiltrating Lymphocyte Therapy: A Case Series

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Tumour‐infiltrating lymphocyte (TIL) therapy is a newly emerged effective treatment for advanced melanoma refractory to immune checkpoint inhibitors; however, its cutaneous adverse effects remain uncharacterized. We present the first case series describing dermatologic adverse effects associated with TIL therapy for malignant melanoma in five ...
Shannon C. Lyden   +9 more
wiley   +1 more source

Diffuse Skin Sclerosis in a Patient With Lung Cancer

open access: yes
JEADV Clinical Practice, EarlyView.
Anna‐Sophia Leven   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy